The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia
Open accessAbstract
Genetic variation in dysbindin (DTNBP1: dystrobrevin-binding protein 1) has recently been shown to be associated with schizophrenia. The dysbindin gene is located at chromosome 6p22.3, one of the most promising susceptibility loci in schizophrenia linkage studies. We attempted to replicate this association in a Japanese sample of 670 patients with schizophrenia and 588 controls. We found a nominally significant association with schizophrenia for four single nucleotide polymorphisms and stronger evidence for association in a multi-marker haplotype analysis (P = 0.00028). We then explored functions of dysbindin protein in primary cortical neuronal culture. Overexpression of dysbindin induced the expression of two pre-synaptic proteins, SNAP25 and synapsin I, and increased extracellular basal glutamate levels and release of glutamate evoked by high potassium. Conversely, knockdown of endogenous dysbindin protein by small interfering RNA (siRNA) resulted in the reduction of pre-synaptic protein expression and glutamate release, suggesting that dysbindin might influence exocytotic glutamate release via upregulation of the molecules in pre-synaptic machinery. The overexpression of dysbindin increased phosphorylation of Akt protein and protected cortical neurons against neuronal death due to serum deprivation and these effects were blocked by LY294002, a phosphatidylinositol 3-kinase (PI3-kinase) inhibitor. SiRNA-mediated silencing of dysbindin protein diminished Akt phosphorylation and facilitated neuronal death induced by serum deprivation, suggesting that dysbindin promotes neuronal viability through PI3-kinase-Akt signaling. Genetic variants associated with impairments of these functions of dysbindin could play an important role in the pathogenesis of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses
Niknian, M. (1995) · Technometrics · doi:10.1080/00401706.1995.10484341 · Cited by 1,462
Brunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,188
d -Serine is an endogenous ligand for the glycine site of the N -methyl- d -aspartate receptor
Mothet, J.-P., Parent, A. T., Wolosker, H., Brady, R. O., Linden, D. J., Ferris, C. D., Rogawski, M. A., & Snyder, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4926 · Cited by 1,137
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341750 · Cited by 856
Self-citationChumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412499 · Cited by 829
Self-citationPrefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Self-citationTokuhiro, S., Yamada, R., Chang, X., Suzuki, A., Kochi, Y., Sawada, T., Suzuki, M., Nagasaki, M., Ohtsuki, M., Ono, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1267 · Cited by 626
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · cited 2×
“Hypofunction of glutamatergic system has been implicated in the neuropathology in schizophrenia (8).”
BackgroundNeuregulin and ErbB receptor signaling pathways in the nervous system
Buonanno, A., & Fischbach, G. D. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00210-5 · Cited by 505
Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J., Hahn, C.-G., Siegel, S. J., Trojanowski, J. Q., Gur, R. E., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420425 · Cited by 455
Li, W., Zhang, Q., Oiso, N., Novak, E. K., Gautam, R., O'Brien, E. P., Tinsley, C. L., Blake, D. J., Spritz, R. A., Copeland, N. G., et al. (2003) · Nature Genetics · doi:10.1038/ng1229 · Cited by 433
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Schwab, S. G., Knapp, M., Mondabon, S., Hallmayer, J., Borrmann-Hassenbach, M., Albus, M., Lerer, B., Rietschel, M., Trixler, M., Maier, W., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345463 · Cited by 354
Weickert, C. S., Straub, R. E., McClintock, B. W., Matsumoto, M., Hashimoto, R., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.544 · Cited by 352
Self-citationMolecular determinants of metabotropic glutamate receptor signaling
De Blasi, A., Conn, P. J., Pin, J.-P., & Nicoletti, F. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01635-7 · Cited by 308
Benson, M. A., Newey, S. E., Martin-Rendon, E., Hawkes, R., & Blake, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010418200 · Cited by 304
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia
Hashimoto, R., Straub, R. E., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Weinberger, D. R. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001434 · Cited by 283
Self-citationProtein phosphorylation and the regulation of synaptic membrane traffic
Turner, K. M., Burgoyne, R. D., & Morgan, A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01436-8 · Cited by 235
The DTNBP1 (Dysbindin) Gene Contributes to Schizophrenia, Depending on Family History of the Disease
Van Den Bogaert, A., Schumacher, J., Schulze, T. G., Otte, A. C., Ohlraun, S., Kovalenko, S., Becker, T., Freudenberg, J., Jönsson, E. G., Mattila-Evenden, M., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379928 · Cited by 193
Williams, N. M., Preece, A., Morris, D. W., Spurlock, G., Bray, N. J., Stephens, M., Norton, N., Williams, H., Clement, M., Dwyer, S., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.336 · Cited by 190
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
Vawter, M. P., Thatcher, L., Usen, N., Hyde, T. M., Kleinman, J. E., & Freed, W. J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001158 · Cited by 188
Recent advances in the genetics of schizophrenia
O’Donovan, M. C., Williams, N. M., & Owen, M. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg302 · Cited by 174
Abnormalities of SNARE Mechanism Proteins in Anterior Frontal Cortex in Severe Mental Illness
Honer, W. G., Falkai, P., Bayer, T. A., Xie, J., Hu, L., Li, H., Arango, V., Mann, J. J., Dwork, A. J., & Trimble, W. S. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.349 · Cited by 161
Family-based association study of DTNBP1 in 6p22.3 and schizophrenia
Tang, J., Zhou, J. P., Fan, J., Li, X. W., Shi, Y., Gu, N. F., Feng, G. Y., Xing, Y. L., Shi, J., & He, L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001287 · Cited by 139
van den Oord, E. J. C. G., Sullivan, P. F., Jiang, Y., Walsh, D., O’Neill, F. A., Kendler, K. S., & Riley, B. P. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001263 · Cited by 133
Numakawa, T., Yamagishi, S., Adachi, N., Matsumoto, T., Yokomaku, D., Yamada, M., & Hatanaka, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109139200 · Cited by 97
Self-citationMorris, D. W., McGhee, K. A., Schwaiger, S., Scully, P. J., Quinn, J., Meagher, D. J., Waddington, J. L., Gill, M., & Corvin, A. P. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00527-3 · Cited by 94
Hashimoto, R., Nakamura, Y., Komai, S., Kashiwagi, Y., Tamura, K., Goto, T., Aimoto, S., Kaibuchi, K., Shiosaka, S., & Takeda, M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750373.x · Cited by 73
Self-citationNumakawa, T., Nakayama, H., Suzuki, S., Kubo, T., Nara, F., Numakawa, Y., Yokomaku, D., Araki, T., Ishimoto, T., Ogura, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304409200 · Cited by 73
Self-citationNumakawa, T., Matsumoto, T., Adachi, N., Yokomaku, D., Kojima, M., Takei, N., & Hatanaka, H. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1201 · Cited by 61
Self-citationNumakawa, T., Yokomaku, D., Kiyosue, K., Adachi, N., Matsumoto, T., Numakawa, Y., Taguchi, T., Hatanaka, H., & Yamada, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202927200 · Cited by 57
Self-citation
Cited by
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Self-citationLisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
“Dysbindin is concentrated in the presynaptic glutamatergic terminals where it interacts with SNAP and synapsin 1 and modulates vesicular release of glutamate [146].”
BackgroundThe neurodevelopmental model of schizophrenia: update 2005
Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. R. C. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001642 · Cited by 993
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
“Dysbindin is concentrated the presynaptic glutamatergic terminals where it interacts with SNAP and synapsin 1 and modulates vesicular release of glutamate (Numakawa et al., 2004).”
BackgroundRoss, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 686
Metadata
- Authors
- Numakawa, T., Yagasaki, Y., Ishimoto, T., Okada, T., Suzuki, T., Iwata, N., Ozaki, N., Taguchi, T., Tatsumi, M., Kamijima, K., Straub, R. E., Weinberger, D. R., Kunugi, H., & Hashimoto, R.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-02
- Volume
- 13
- Issue
- 21
- Pages
- 2699-2708
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2154340693
- Cited by
- 349
- References
- 34
- FWCI
- 20.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.